Within just days, representatives of a tiny company in Maryland will meet face to face with a giant government agency in Silver Spring, Md., with a bold request.
The company is asking the FDA for a special approval for its revolutionary product. If granted, it has the potential to shake up the entire biotech sector.
And word on the street is, it will be a slam dunk.
Right now this stock costs less than a penny per share… but that could change very soon.
In fact, similar set ups have already returned a rare 550%, 720%, and even 1,123% gains in the last few years.
But time is running out to get in before the May 29th trigger event.
Enter your email address below to get the full details on the upcoming FDA meetings, along with the ticker symbol for this company. You’ll also get free ongoing updates from Profitable News.